Michael Hoenig, DPM
Podiatrist · Saint Louis, MONPI 1760851539
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,989 of the $4,946 with a category attached, or 60.4%. Stryker accounts for 88.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $4,068 and has fallen 96.4% since, to $147 in 2024.
Across 60 payments — averaging $82.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Johnson & Johnson$158
- Kerecis Limited$118
- Trilliant Surgical LLC.$97
- Nevro Corp.$45
- Organogenesis Inc.$29
- plus $110 from 5 others
What the payments were for
- Travel & lodging$1,95740%
- Food & beverage$2,98960%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 44 | $4,390 |
| Johnson & Johnson | 3 | $158 |
| Kerecis Limited | 3 | $118 |
| Trilliant Surgical LLC. | 1 | $97 |
| Nevro Corp. | 1 | $45 |
| Organogenesis Inc. | 1 | $29 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $28 |
| Orthofix Medical, Inc. | 2 | $24 |
| Smith+Nephew | 2 | $24 |
| Bioventus LLC | 1 | $23 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,946 in reported general payments places this provider in the 80th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 14 | $624 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $402 |
| Gabapentin | 48 | $390 |
| Ciclopirox | 25 | $349 |
| Ammonium Lactate | 11 | $340 |
| Doxycycline Hyclate | 13 | $88 |
| Terbinafine Hcl | 14 | $74 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Saint Louis
- Kiera Benge-SheaSaint Louis$28K
- Neil ErmitanoSaint Louis$14K
- Daniel NarowitzSaint Louis$12K
- Jay MoradiaSaint Louis$11K
- Tracy ReedSaint Louis$8K
- Matthew ClaxtonSaint Louis$5K
- Caleb WhiteSaint Louis$4K
- Christopher ForsbachSaint Louis$3K
- Stephen SehySaint Louis$1K
- Michael HorwitzSaint Louis$899
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.